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Socioeconomic position and the COVID-19 care cascade from 
testing to mortality in Switzerland: a population-based 
analysis
Julien Riou*, Radoslaw Panczak*, Christian L Althaus, Christoph Junker, Damir Perisa, Katrin Schneider, Nicola G Criscuolo, Nicola Low, 
Matthias Egger
Summary
Background The inverse care law states that disadvantaged populations need more health care than advantaged 
populations but receive less. Gaps in COVID-19-related health care and infection control are not well understood. We 
aimed to examine inequalities in health in the care cascade from testing for SARS-CoV-2 to COVID-19-related 
hospitalisation, intensive care unit (ICU) admission, and death in Switzerland, a wealthy country strongly affected by 
the pandemic.
Methods We analysed surveillance data reported to the Swiss Federal Office of Public Health from March 1, 2020, to 
April 16, 2021, and 2018 population data. We geocoded residential addresses of notifications to identify the Swiss 
neighbourhood index of socioeconomic position (Swiss-SEP). The index describes 1·27 million small neighbourhoods 
of approximately 50 households each on the basis of rent per m², education and occupation of household heads, and 
crowding. We used negative binomial regression models to calculate incidence rate ratios (IRRs) with 95% credible 
intervals (CrIs) of the association between ten groups of the Swiss-SEP index defined by deciles (1=lowest, 10=highest) 
and outcomes. Models were adjusted for sex, age, canton, and wave of the epidemic (before or after June 8, 2020). We 
used three different denominators: the general population, the number of tests, and the number of positive tests.
Findings Analyses were based on 4 129 636 tests, 609 782 positive tests, 26 143 hospitalisations, 2432 ICU admissions, 
9383 deaths, and 8 221 406 residents. Comparing the highest with the lowest Swiss-SEP group and using the general 
population as the denominator, more tests were done among people living in neighbourhoods of highest SEP 
compared with lowest SEP (adjusted IRR 1·18 [95% CrI 1·02–1·36]). Among tested people, test positivity was lower 
(0·75 [0·69–0·81]) in neighbourhoods of highest SEP than of lowest SEP. Among people testing positive, the adjusted 
IRR was 0·68 (0·62–0·74) for hospitalisation, was 0·54 (0·43–0·70) for ICU admission, and 0·86 (0·76–0·99) for 
death. The associations between neighbourhood SEP and outcomes were stronger in younger age groups and we 
found heterogeneity between areas.
Interpretation The inverse care law and socioeconomic inequalities were evident in Switzerland during the COVID-19 
epidemic. People living in neighbourhoods of low SEP were less likely to be tested but more likely to test positive, be 
admitted to hospital, or die, compared with those in areas of high SEP. It is essential to continue to monitor testing 
for SARS-CoV-2, access and uptake of COVID-19 vaccination and outcomes of COVID-19. Governments and health-
care systems should address this pandemic of inequality by taking measures to reduce health inequalities in response 
to the SARS-CoV-2 pandemic.
Funding Swiss Federal Office of Public Health, Swiss National Science Foundation, EU Horizon 2020, Branco Weiss 
Foundation.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 
license.
Introduction
The pandemic of SARS-CoV-2 infections has created 
unprecedented challenges for society and health-care 
systems worldwide. Europe has been heavily affected by 
the pandemic, with over 55 million confirmed cases and 
over 1·1 million deaths as of mid-June, 2021, .1 Compared 
with neighbouring countries, Switzerland had a high rate 
of confirmed COVID-19 cases, higher than those of Austria 
and Italy, and almost double the rate in Germany.2 
Similarly, there was substantial excess mortality in 
Switzerland during the first wave and the highest excess 
mortality among neighbouring countries during the 
second wave.3
Published in 1971, the inverse care law states that “the 
availability of good medical care tends to vary inversely 
with the need for it in the population served.”4,5 
Inequalities in health are a concern in many regions, 
including in Europe.6 In Switzerland, life expectancy 
varies between neighbourhoods, depending on the 
neighbourhood’s socioeconomic position (SEP).7 Health 
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inequalities and inequities might also influence the 
outcomes of the COVID-19 pandemic.8 A study in 
Massachusetts, USA, SARS-CoV-2 testing resources had 
been disproportionately allocated to more affluent 
communities. In the UK Biobank cohort, testing positive 
for SARS-CoV-2 was related to area-level socioeconomic 
deprivation, lower educational level, and non-White 
ethnicity.9 The REal-time Assessment of Community 
Transmission-2 (REACT-2) study, in England, showed a 
higher prevalence of people with SARS-CoV-2 antibodies 
in neighbourhoods with high levels of social disadvantage 
and among minority ethnic communities.10 Studies in 
the USA showed that patients from neighbourhoods or 
counties with lower median income or higher deprivation 
were more likely to require intensive care, and more 
likely to die from COVID-19.11,12
Inequalities and inequities in health care and infection 
control should be described and documented at the 
population level along the COVID-19 cascade—ie, from 
testing and testing positive to medical care and clinical 
outcomes. We analysed nationwide, population-based 
surveillance data from the Swiss Federal Office of Public 
Health (SFOPH) to examine the association of 
neighbourhood SEP with testing for SARS-CoV-2, 
testing positive, hospitalisation, intensive care unit 
(ICU) admission, and death.
Methods
Data sources
In this population-based study of surveillance data, we 
used mandatory notifications for negative and positive 
SARS-CoV-2 tests, and for laboratory-confirmed hos-
pitalisations and deaths related to COVID-19, received at 
the SFOPH until April 14, 2021.13 PCR testing capacity 
was low during the first wave and tests were mainly 
used for hospitalised patients with severe symptoms 
Research in context
Evidence before this study
Mounting evidence exists that the COVID-19 pandemic 
increased socioeconomic inequalities. We used the COAP Living 
Evidence on COVID-19 platform to identify relevant literature. 
This data platform gathers articles and preprints reporting 
COVID-19-related research from PubMed and preprint servers 
from Jan 1, 2020, onwards. On April 29, 2021, we searched the 
platform using the terms (socioeconomic status) OR 
(socioeconomic position) OR (inequalities) OR (disparities) AND 
(infection) OR (testing) OR (hospitalisation) OR 
(hospitalization) OR (death) OR (mortality). We identified 
published papers and preprints from China, India, Europe, 
North America, and Latin America. Most researchers analysed 
geographically aggregated data and focused on the effect of 
socioeconomic position (SEP) on the number of COVID-19 
cases or deaths, at the level of counties or districts, using data 
from the first wave in spring 2020. These studies showed that 
rates of reported COVID-19 cases were associated with 
populations living in areas of lower SEP, who were more mobile 
than those from more affluent areas. Few studies examined 
testing patterns for SARS-CoV-2 testing. One study showed 
that, in Massachusetts, USA, testing resources had been 
disproportionately allocated to more affluent communities 
than poorer communities. A study in the city of Santiago, Chile, 
showed that the association between testing intensity and 
higher SEP reversed, with more tests in the most affected areas 
of lower SEP later in the wave. No study examined the 
nationwide effect of SEP at high spatial resolution and along 
the entire care cascade.
Added value of this study
This study took advantage of national surveillance data 
covering the whole cascade from testing for SARS-CoV-2 to the 
need for hospital care and death in Switzerland. 
Most notifications could be geocoded and linked to the Swiss 
neighbourhood index of SEP, resulting in large sample sizes. 
The data showed that people living in areas of higher SEP were 
more likely to get tested for SARS-CoV-2 but less likely to test 
positive, be admitted to hospital or the intensive care unit, 
and less likely to die, compared with those in areas of lower SEP. 
In the unique setting of a pandemic, this study illustrates the 
inverse care law (the availability of good medical care tends to 
vary inversely with the need for it in the population served), 
which Julian Tudor Hart formulated 50 years ago. The analysis 
used data up to mid-April, 2021, and thus covered the first and 
second waves of the pandemic in 2020 and the subsequent 
increase in the number of cases observed since 
mid-February, 2021. Analyses used state-of-the-art statistical 
methods and three different denominators: the general 
population, the total number of tests, and the number of 
positive tests. Results were consistent across these 
denominators.
Implications of all the available evidence
Taken together, the evidence shows that the inverse care law 
and socioeconomic inequalities manifested themselves during 
the COVID-19 epidemic, both in wealthy Switzerland and 
lower-income countries. The pandemic has accentuated 
socioeconomic inequalities in health in many countries. 
Analyses incorporating COVID-19 surveillance data with 
publicly available census data can identify the communities and 
neighbourhoods most affected by the pandemic. The public 
health response to COVID-19 should address the socioeconomic 
constraints on following physical distancing rules, isolation, 
and quarantine. The design of information campaigns and 
testing and vaccination programmes should take variation in 
social, spatial, and digital access into account to minimise 
inequalities in outcomes. Governments and health-care 
systems should include measures to reduce health inequalities 
in their preparedness plans for future pandemics.
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compatible with COVID-19. Since June 24, 2020, the 
Swiss Federal Government has covered the costs of PCR 
tests, including for people with mild symptoms, those 
who were notified by the digital contact tracing app, 
SwissCovid, and people who were asked by health 
authorities to get tested following close contact with an 
infected person. Additionally, on Jan 27, 2021, the Federal 
Government expanded the criteria for reimbursement by 
covering the costs of tests in people without symptoms, 
and on March 12, 2021, by covering up to five rapid tests 
per month. We included records with a date after 
Feb 29, 2020 (May 22, 2020, for negative tests), from 
Swiss residents. We excluded notifications with missing 
or invalid information on age, sex, or place of residence, 
and duplicate notifications. We geocoded the residential 
address using geocoded general population data from 
the Swiss Federal Statistical Office (2018 edition).14 We 
used population data from 2018 and the directory of 
retirement and nursing homes to identify individuals 
living in such institutions.15
Index of neighbourhood SEP
The Swiss neighbourhood index of SEP (Swiss-SEP) is 
based on the national house-to-house census from 2000.16 
Swiss-SEP includes 1·27 million neighbourhoods of 
approximately 50 households each, centred on the 
individual’s residential building, with overlapping 
boundaries. The index uses the median rent per m², the 
proportion of households headed by a person with 
primary education or less, the proportion headed by a 
person in manual or unskilled occupation, and the mean 
number of people per room (crowding) to characterise 
neighbourhoods. No data on household income are 
collected in the Swiss census. The index was constructed 
using principal component analysis and validated using 
independent data on households’ financial situation16 and 
was standardised to range from 0 (lowest SEP) to 100 
(highest SEP).
Geocoding and linkage to Swiss-SEP
Geocoding of the residential addresses was done using 
the publicly available data from the Swiss Federal Office 
of Topography or, in a few cases, using Google Maps 
Geocoding API. Swiss-SEP index values were aggregated 
into ten groups using deciles as cutoffs. Where only a 
postcode was available, we used the Swiss-SEP value 
corresponding to the centroid of the area. Data were 
aggregated by canton (26 groups), sex (two groups), age 
(nine groups: 10-year groups from 0 years to 79 years and 
≥80 years), Swiss-SEP (ten groups), and epidemic wave 
(two groups: before June 8, 2020 [14 weeks], or from 
June 8, 2020, onwards [35 weeks]) at the SFOPH. 
June 8, 2020, was the beginning of the first week after the 
nadir of case counts. The dataset consisted of aggregated 
data only. We did this research using surveillance data 
according to the Swiss law on communicable diseases 
(EpG, SR 818.101). No ethics approval was required.
Statistical analysis
We examined the association between Swiss-SEP group 
and counts of SARS-CoV-2 tests, positive tests, hos-
pitalisations, ICU admissions, and deaths in negative 
binomial regression models to account for unknown 
overdispersion. We used a Bayesian approach with weakly 
informative priors to improve the inference in situations 
with low numbers (eg, deaths in the age group 0–49 years) 
or multiple interactions. We considered three different 
denominators: the general population, the total number of 
tests, and the number of positive tests. Denominators were 
included as offsets in each model. In a univariate model, 
we estimated the incidence rate ratio (IRR) with 
95% credibility intervals (CrIs) per unit increase in Swiss-
SEP group for each outcome and denominator. The model 
assumes that the association with Swiss-SEP is linear on 
the logarithmic scale. We tested this assumption by 
comparing this model with one in which each group was 
included separately. We estimated the IRR adjusted for age 
group, sex, canton, and epidemic wave in a second model. 
The adjustment for canton included a random intercept 
and slope by canton, allowing for interaction between 
Swiss-SEP group and canton. In a third model, we assessed 
two-way interactions between Swiss-SEP, and age group, 
sex, and epidemic wave. We used the leave-one-out 
information criterion for model selection.17
In sensitivity analyses, we (1) excluded all cases 
geocoded with the postal code and not the full address 
and (2) excluded cases with an address corresponding to 
one of 1586 retirement or nursing homes. All analyses 
were done using Stan (version 2.21.1)18 and R (version 
4.0.4), with package rstanarm. We used weakly 
informative prior distributions for all model parameters.17 
Calculations were done on UBELIX. The appendix (p 4) 
provides more information.
Figure 1: Evolution of notifications to the Federal Office of Public Health during the COVID-19 pandemic in 
Switzerland from March 1, 2020, to April 14, 2021
The counts of total tests were available only from May 23, 2020. The dashed line shows the date chosen for the 


















Total tests Positive tests Hospitalisations ICU admissions Deaths
For more on UBELIX see 
http://www.id.unibe.ch/hpc
See Online for appendix
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Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report.
Results
As of April 14, 2021, the SFOPH received 6 872 353 noti-
fications related to COVID-19 during two epidemic 
waves (figure 1). 5 910 732 SARS-CoV-2 test res- 
 ults, 616 239 (10·4%) positive SARS-CoV-2 tests, 
26 373 COVID-19 hospital admissions (4·3% of positive 
tests), 2458 COVID-19 ICU admissions (0·4% of 
positive cases), and 9550 deaths from COVID-19 (for a 
case fatality rate of 1·5%) met eligibility criteria 
(appendix p 2). Valid information on age, sex, and place 
of residence was available for 4 129 636 (69·9%) tests, 
609 782 (99·0%) positive tests, 26 143 (99·1%) 
hospitalisations, 2432 (98·9%) ICU admissions, 
and 9383 (98·3%) deaths. In approximately 95% of 
geocoded notifications, geocoding was based on 
the exact address (appendix p 3). Few geocodes 
corresponded to retirement or nursing homes, ranging 
from 63 (2·1%) of 2432 people admitted to ICU to 
1194 (4·6%) of 26 143 people admitted to hospital. For 
deaths, 3178 notifications (33·9%) were from such 
retirement or nursing homes (appendix p 3).
Table 1 shows the observed distribution of geocoded 
notifications and the 2018 general population across age, 
sex, epidemic wave, and Swiss-SEP group. Approximately 
40% of the Swiss population is aged 50 years or older. This 
age group accounted for 33·0% of all SARS-CoV-2 tests 
and for 38·9% of positive tests, but for 88·2% of 
hospitalisations, 92·8% of ICU admissions and 99·6% of 
deaths (table 1). Women contributed more tests and more 
positive tests than men did (table 1). Men accounted 
for most hospitalisations, ICU admissions, and deaths 
(table 1). The group of lowest SEP accounted for 
82 977 (13·6%) of 609 782 positive tests, 4045 (15·5%) 
of 26 143 hospitalisations, 398 (16·4%) of 2432 ICU 
admissions, and 1240 (13·2%) of 9383 deaths, whereas the 
highest SEP accounted for 43 466 (7·1%) positive tests, 
1469 (5·6%) hospitalisations, 119 (4·9%) ICU admissions, 
Total tests* Positive tests Hospitalisations ICU admissions Deaths Population
Total 4 129 636 609 782 26 143 2432 9383 8 221 406
Age, years
0–9 140 728 (3·4%) 10 384 (1·7%) 267 (1·0%) 11 (0·5%) 2 (0·0%) 850 207 (10·3%)
10–19 476 206 (11·5%) 57 342 (9·4%) 151 (0·6%) 7 (0·3%) 1 (0·0%) 816 042 (9·9%)
20–29 746 922 (18·1%) 104 977 (17·2%) 450 (1·7%) 17 (0·7%) 2 (0·0%) 1 017 569 (12·4%)
30–39 770 815 (18·7%) 102 729 (16·8%) 749 (2·9%) 39 (1·6%) 9 (0·1%) 1 181 147 (14·4%)
40–49 635 320 (15·4%) 96 941 (15·9%) 1489 (5·7%) 100 (4·1%) 32 (0·3%) 1 170 313 (14·2%)
50–59 584 916 (14·2%) 100 649 (16·5%) 3180 (12·2%) 309 (12·7%) 162 (1·7%) 1 239 500 (15·1%)
60–69 343 966 (8·3%) 57 595 (9·4%) 4572 (17·5%) 639 (26·3%) 588 (6·3%) 898 741 (10·9%)
70–79 217 158 (5·3%) 37 102 (6·1%) 6566 (25·1%) 884 (36·3%) 1882 (20·1%) 675 413 (8·2%)
≥80 213 605 (5·2%) 42 063 (6·9%) 8719 (33·4%) 426 (17·5%) 6705 (71·5%) 372 474 (4·5%)
Sex
Male 1 964 095 (47·6%) 291 218 (47·8%) 14 960 (57·2%) 1773 (72·9%) 5045 (53·8%) 4 081 536 (49·6%)
Female 2 165 541 (52·4%) 318 564 (52·2%) 11 183 (42·8%) 659 (27·1%) 4338 (46·2%) 4 139 870 (50·4%)
COVID-19 wave
First wave† 35 375 (0·9%) 28 018 (4·6%) 3929 (15·0%) 533 (21·9%) 1575 (16·8%) ··
Second wave‡ 4 094 261 (99·1%) 581 764 (95·4%) 22 214 (85·0%) 1899 (78·1%) 7808 (83·2%) ··
Neighbourhood index of SEP (group)
1 (lowest) 452 438 (11·0%) 82 977 (13·6%) 4045 (15·5%) 398 (16·4%) 1240 (13·2%) 983 036 (12·0%)
2 436 720 (10·6%) 71 319 (11·7%) 3366 (12·9%) 354 (14·6%) 1140 (12·1%) 885 376 (10·8%)
3 410 169 (9·9%) 65 886 (10·8%) 2999 (11·5%) 274 (11·3%) 1042 (11·1%) 842 747 (10·3%)
4 404 986 (9·8%) 61 757 (10·1%) 2796 (10·7%) 254 (10·4%) 977 (10·4%) 827 400 (10·1%)
5 408 730 (9·9%) 60 782 (10·0%) 2622 (10·0%) 243 (10·0%) 1033 (11·0%) 825 493 (10·0%)
6 404 213 (9·8%) 59 654 (9·8%) 2533 (9·7%) 227 (9·3%) 1044 (11·1%) 813 598 (9·9%)
7 408 996 (9·9%) 56 701 (9·3%) 2289 (8·8%) 193 (7·9%) 825 (8·8%) 809 336 (9·8%)
8 402 915 (9·8%) 55 093 (9·0%) 2137 (8·2%) 187 (7·7%) 864 (9·2%) 791 945 (9·6%)
9 392 818 (9·5%) 52 147 (8·6%) 1887 (7·2%) 183 (7·5%) 644 (6·9%) 758 723 (9·2%)
10 (highest) 407 651 (9·9%) 43 466 (7·1%) 1469 (5·6%) 119 (4·9%) 574 (6·1%) 683 752 (8·3%)
Data are n (%). ICU=intensive care unit. SEP=socioeconomic position. *Data on total tests relate to the period May 23, 2020, to April 14, 2021, rather than the full study 
period from March 1, 2020, to April 14, 2021. †The first wave of infections was before June 8, 2020. ‡The second wave was from June 8, 2020.
Table 1: Distribution of study data across age, sex, and neighbourhood index of SEP
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and 574 (6·1%) deaths (table 1). In the general population, 
the number of people living in neighbourhoods of lower 
SEP is higher than in neighbourhoods of higher position. 
Most of the data were from the second wave, which lasted 
longer and was more severe than the first; 7808 (83·2%) 
deaths were from the second wave (table 1).
The rates of SARS-CoV-2 tests per population increased 
with Swiss-SEP group (figure 2), whereas the rates 
decreased for positive tests, hospitalisations, ICU 
admissions, and deaths. The slopes for positive tests, 
hospitalisations, and ICU admissions were steeper when 
rates were calculated per test rather than by population, 
and somewhat less steep when expressed per positive test 
(figure 2).
Modelling Swiss-SEP groups as a continuous variable 
led to a similar or better model fit than with discrete 
variables (appendix p 5). Adjusting for age, sex, epidemic 
wave, and canton improved the fit further (appendix p 
5). Visual comparison of model predictions and 
observed data from the latter model illustrates the good 
fit, with most observed data points within the 95% CrI 
of model estimates (appendix p 6). One exception was 
the high number of tests among people living 
in neighbourhoods in the highest Swiss-SEP group, 
which was not captured well. Additionally, several data 
points were outside the CrI for positive tests per 
population. The fit improved for positive tests when 
stratifying the data by epidemic wave (appendix p 14).
In both unadjusted and adjusted analyses, each 
increase in Swiss-SEP group was associated with an 
increase in SARS-CoV-2 testing per population 
(figure 3). The adjusted IRR was 1·02 (95% CrI 
1·00–1·03) per group increase, corresponding to 18% 
(2–36) more tests in the highest compared with the 
lowest socioeconomic group (table 2). We did not find 
any association with positive tests per population 
(figure 3). The number of positive tests per number of 
tests decreased as Swiss-SEP group increased (adjusted 
IRR 0·97 [0·96–0·98]), corresponding to a 25% (19–31) 
lower test positivity in the highest compared with the 
lowest socio economic group (figure 3). The greater 
uptake of testing in neighbourhoods of higher 
socioeconomic position masked the higher number of 
positive tests among individuals from lower SEP than 
in higher SEP neighbourhoods. Rates of hospitalisations 
(adjusted IRR 0·94 [0·92–0·96]) and ICU admissions 
(0·90 [0·87–0·93] per population decreased with higher 
SEP, corresponding to 44% (33–51) lower hospitalisation 
rates and 61% (47–72) lower ICU admission rates in the 
highest compared with the lowest socioeconomic group 
(figure 3). Estimates were similar in the unadjusted 
and adjusted analyses, and similar with different 
denominators (table 2; figure 3).
COVID-19-related mortality declined with increasing 
SEP of neighbourhoods (table 2). The association became 
stronger when excluding residents of retirement or 
Figure 2: Counts of notified SARS-CoV-2 tests, positive tests, hospitalisations, ICU admissions, and deaths across groups of SEP per 100 000 population, tests, or positive tests
Higher SEP groups correspond to neighbourhoods of higher SEP. The study period was March 1, 2020, to April 14, 2021, except for total tests that only covered May 23, 2020, to April 14, 2021. 
ICU=intensive care unit. SEP=socioeconomic position.
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nursing homes (figure 4A). After excluding such 
residents, the adjusted IRRs per increase in Swiss-SEP 
group were 0·94 (95% CrI 0·92–0·97) for COVID-19 
deaths per population, 0·94 (0·93–0·96) for deaths 
among those tested and 0·98 (0·96–0·99) for deaths 
among those testing positive (figure 4A, appendix p 17). 
These estimates translated into a lower mortality of 40% 
(24–52) per population, 40% (29–49) per test, and 18% 
(7–28) per positive test, comparing the highest with the 
lowest group (figure 4A).
Rates of testing, positive tests, and clinical outcomes 
were also associated with age and sex (appendix p 8). The 
testing rate per 100 000 population was lowest and 
positive tests were the least frequent in children aged 
0–9 years (appendix p 9). The risk of hospitalisation 
increased with age and ICU admissions and mortality 
increased from age 50 years onwards. Testing and 
positive tests were about as frequent among men and 
women but the rates of hospitalisations, ICU admissions, 
and mortality were all lower in women than in men. For 
all outcomes, we found heterogeneity across cantons 
(appendix p 9).
We examined two-way interactions between Swiss-SEP 
group and age, sex, epidemic wave, and canton (appendix 
pp 10–12). The associations between SEP and outcomes 
became weaker with increasing age (appendix pp 10–12). 
The interaction with age is illustrated in figure 4B for 
mortality in those testing positive. The association with 
neighbourhood SEP became weaker moving from age 
group 0–49 years to older age groups and disappeared in 
the age group 80 years and older (appendix pp 10–12). We 
found little evidence of interactions with sex or epidemic 
wave. There was also heterogeneity across cantons, 
particularly for testing and positive tests. The canton of 
Geneva was an outlier, with a stronger positive association 
of Swiss-SEP group with testing and a stronger negative 
association with test positivity compared with the 
national average. Associations with testing and test 
positivity were also somewhat stronger for the cantons of 
Bern, Obwalden, and Uri, and weaker or absent for other 
cantons (appendix pp 10–12).
Discussion
In this whole-population study of the COVID-19 
epidemic in Switzerland in 2020–21, we found that 
people living in areas with higher SEPs were more 
likely to get tested for SARS-CoV-2 but less likely to test 
positive and be admitted to hospital or the ICU, and 
less likely to die, compared with those in areas of lower 
SEP. The strength of the association increased moving 
along the care cascade from test positivity to 
hospitalisation and ICU admission. Associations with 
neighbourhood SEP were similar during the two waves 
but more pronounced in some areas than others. 
Testing was less intense and positive tests less frequent 
in children. The risk of hospitalisation increased 
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Figure 3: Unadjusted and adjusted IRRs per increase in the group of neighbourhood SEP for the counts of SARS-CoV-2 tests, positive tests, hospitalisations, 
ICU admissions, and mortality per population, tests or positive tests
Median posteriors and 95% credibility intervals are shown in each case. IRR estimates higher than 1 correspond to a positive association with Swiss neighbourhood 
index of SEP groups; estimates lower than 1 correspond to a negative association. Adjusted estimates are adjusted for age, sex, canton, and epidemic wave. The study 
period was March 1, 2020, to April 14, 2021, except for total tests, which covered May 23, 2020, to April 14, 2021. ICU=intensive care unit. IRR=incidence rate ratio. 
SEP=socioeconomic position.
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continuously with age, and ICU admissions and 
mortality increased from age 50 years onwards, in line 
with a previous study.19 Testing and positive tests were 
about as frequent among men and women, but 
hospitalisations, ICU admissions, and mortality were 
all higher in men than in women, again confirming 
previous findings.20
We used national data for one country and its health 
system and covered the cascade from testing for SARS-
CoV-2 to testing positive, hospital admission, death, in 
both waves of the COVID-19 epidemic for all ages. Our 
study of the Swiss resident population thus avoided the 
selection bias affecting many COVID-19 studies—eg, 
studies of patients admitted to hospital.21 Another strength 
is the use of the Swiss-SEP index, which has criterion 
validity, with mean household income continuously 
increasing from the lowest to highest SEP group, based 
on data from more than 1 million small neighbourhoods 
centred on individuals’ residences.16
We examined the association with SEP in 
three different populations: the general population, the 
population tested for SARS-CoV-2, and the group with 
positive tests. Associations were consistent across the 
three populations, except for the rate of positive tests in 
the population. The greater uptake of testing in higher 
SEP neighbourhoods masked the higher number of 
positive tests in those of lower SEP. The data also have 
weaknesses that limit interpretation. Each outcome is 
likely to be affected by some level of under-reporting, 
possibly creating bias if under-reporting is associated 
with SEP. However, individuals in lower SEP 
neighbourhoods might be more affected by under-
reporting, meaning that our results would underestimate 
the association between SEP and test positivity, hospital 
admissions and deaths. The data on tests are limited by 
the absence of complete data on reasons for testing: the 
lower test positivity among young children could thus 
reflect that children were more likely to be tested for 
infection control rather than because of symptoms, 
compared with those in older age groups. Alternatively, 
the lower test positivity could indicate a lower 
susceptibility to SARS-CoV-2 infection in this age group. 
Not all notifications could be geocoded because of 
incomplete addresses. The Swiss-SEP index of 
retirement and nursing homes might not reflect the 
neighbourhood where residents spent most of their 
lives, thus misclassifying their SEP. This limitation 
might explain why the strength of the association 
increased when excluding deaths in residents of these 
institutions. Finally, the Swiss-SEP index is based on the 
2000 census, although it continues to be strongly 
associated with income and mortality.22
Data on indicators of SEP are often not collected 
in clinical studies or routine surveillance systems. 
Khalatbari-Soltani and colleagues8 observed that, up to 
April, 2020, no study about COVID-19 had reported data 
on socioeconomic indicators such as educational level, 
income, or housing conditions.8 Since then, several 
studies have found associations between area-level 
deprivation and SARS-CoV-2 infection, increased 
severity of COVID-19 disease, and mortality.10–12,23,24 In 
common with these studies, our study used a small 
area-based measure of SEP. Area-based measures are 
more readily available than individual measures and 
have the advantage of capturing effects at the level of 
both the individual and the place. A seroprevalence 
study in the canton of Geneva, Switzerland, in 2020, did 
not find strong associations with individual-level 
indicators of social position, other than becoming 
unemployed.25 However, the study population was not 
representative of the population of Geneva, including 
many more individuals with tertiary education, fewer 
with mandatory school only, and fewer non-Swiss 
nationals compared with the general population.26 A 
Swedish study used individual-level data from 
population-based registers and found that people with 
lower income and level of education and immigrants 
from low-income or middle-income countries were at 
higher risk of death from COVID-19.27 Data on ethnicity 
are not recorded in the Swiss surveillance system, which 
is a weakness of our study. Of note, the proportion of 
non-White individuals in the Swiss population is less 
than 5%. A study of COVID-19 outcomes up to the end 
of 2020 in 17 million adults in England showed an 
increased risk of testing positive for SARS-CoV-2 and 
adverse outcomes in minority ethnic populations.28 A 
strength of both our study and the English study28 is that 
Unadjusted IRR per Swiss-
SEP group increase 
(95% CrI)
Adjusted IRR per Swiss-
SEP group increase
(95% CrI)
Adjusted IRR comparing 
highest and lowest Swiss-
SEP group (95% CrI)
Total tests*
Per population 1·02 (1·01–1·04) 1·02 (1·00–1·03) 1·18 (1·02–1·36)
Positive tests
Per population 0·99 (0·98–1·00) 0·99 (0·98–1·01) 0·95 (0·84–1·11)
Per total test* 0·97 (0·97–0·98) 0·97 (0·96–0·98) 0·75 (0·69–0·81)
Hospitalisations
Per population 0·94 (0·92–0·95) 0·94 (0·92–0·96) 0·56 (0·49–0·67)
Per total test* 0·94 (0·92–0·95) 0·92 (0·91–0·94) 0·49 (0·43–0·56)
Per positive test 0·96 (0·95–0·98) 0·96 (0·95–0·97) 0·68 (0·62–0·74)
ICU admissions
Per population 0·92 (0·89–0·94) 0·90 (0·87–0·93) 0·39 (0·28–0·53)
Per total test* 0·90 (0·87–0·93) 0·90 (0·88–0·93) 0·40 (0·31–0·53)
Per positive test 0·93 (0·91–0·96) 0·93 (0·91–0·96) 0·54 (0·43–0·70)
Deaths
Per population 0·96 (0·93–0·99) 0·96 (0·92–1·01) 0·71 (0·49–1·10)
Per total test* 0·98 (0·94–1·01) 0·96 (0·94–0·98) 0·66 (0·57–0·82)
Per positive test 0·97 (0·95–1·00) 0·98 (0·97–1·00) 0·86 (0·76–0·99)
Three denominators were considered: population, total tests, and positive tests. CrI=credibility interval. IRR=incidence 
rate ratio. Swiss-SEP=Swiss neighbourhood index of socioeconomic position. *Data on total tests relate to the period 
May 23, 2020, to April 14, 2021, rather than the full study period from March 1, 2020, to April 14, 2021.
Table 2: Association of Swiss-SEP group with five outcomes related to SARS-CoV-2 surveillance and care
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they covered the entire cascade from testing to mortality 
at the national level. Previous studies were often based 
on population surveys, with unequal participation 
across socioeconomic and ethnic groups,9,10,25,26 excluded 
children,9,10 or were restricted to selected hospitals, 
areas, or cities.11,23,24
50 years ago, Tudor Hart proposed the inverse care 
law, which stipulates that “the availability of good 
medical care tends to vary inversely with the need for it 
in the population served.”4 In 2000, Victora and 
colleagues29 proposed an analogous inverse equity 
hypothesis, which states that new health interventions 
are initially adopted by the wealthier segments of a 
population who have the least need. Our study bears 
out both hypotheses in the unique setting of a 
pandemic. Early diagnosis of SARS-CoV-2 infections 
and adequate initial management might improve the 
prognosis of individuals with COVID-19, whereas 
prognosis is worse in patients diagnosed late, with low 
oxygen saturation and signs of pneumonia.30 Rapid 
diagnosis and isolation are the key to preventing 
transmission; communities with higher testing levels 
will benefit from lower rates of transmission. The 
SARS-CoV-2 tests were a new technology and testing 
capacity was limited in Switzerland, particularly during 
the first wave of the pandemic. In both waves, testing 
was less intense in neighbourhoods of lower SEP. 
People living in these areas might have had less access 
to test centres because of reduced access to private 
transport or an inability to take time off work. Greater 
availability of testing and conditions that eased uptake 
in these areas could have improved outcomes and 
reduced transmission.
The higher rate of positive tests in neighbourhoods of 
lower SEP might reflect higher risks of SARS-CoV-2 
infection at work and at home. People in manual 
occupations are unable to work from home and are 
likely to have more unprotected contacts with others, on 
building sites, or in factories compared with those who 
could work from home. At home, living conditions 
might also be more crowded in lower SEP areas than in 
higher SEP areas. A study from the USA used mobile 
phone data to show that the adoption of physical 
distancing was lower in counties with higher 
proportions of people below the poverty level.31 Detailed 
maps of the SEP of Swiss neighbourhoods have been 
published.16 Health policy measures should consider the 
susceptibility of different communities and prevent 
inequities in health and infection control. The Swiss 
National COVID-19 Science Taskforce recommended 
that, in this unpredictable crisis, the state should 
assume the role of insurer and cushion the negative 
effects with appropriate economic and social policies.32 
Without such support, those affected will understandably 
not favour control measures that threaten their 
livelihoods.
Switzerland is one of the wealthiest countries globally, 
with wealth more unequally distributed than in other 
European countries—the Gini coefficient is estimated at 
0·86 using 2015 tax data.33 Switzerland has a well developed 
health-care system and universally mandated health 
insurance, which in principle guarantees access to care for 
all. The Swiss health-care system has been described as 
providing a good balance between individual responsibility 
and community solidarity,34 but evidence exists that high 
out-of-pocket payments, including co-payments and 
deductibles, might prompt some individuals not to seek 
care. A survey in the canton of Geneva35 showed that up to 
31% of respondents reported having foregone health care 
for economic reasons depending on income. In our study, 
Geneva was the canton with the strongest association 
between neighbourhood SEP and testing. Geneva also had 
the highest Gini index for wealth (0·92).33
In conclusion, this nationwide study found that people 
living in neighbourhoods of higher SEP are more likely to 
be tested in Switzerland but less likely to test positive, be 
hospitalised, or die, compared with those living in areas of 
lower SEP. The higher incidence of SARS-CoV-2 
infections, combined with a higher prevalence of 
comorbidities in neighbourhoods of lower SEP compared 
with higher SEP is likely to have contributed to worse 
outcomes, including the higher risk of hospitalisation and 
death. By June 2021, vaccination coverage had increased 
considerably, with over 40% of the population having 
received at least one dose of SARS-CoV 2 vaccine, and the 
Government is gradually easing preventive measures. It is 
essential to continue to monitor testing for SARS-CoV-2, 
Figure 4: Adjusted IRRs from sensitivity analyses
 (A) Adjusted IRRs per increase in group of neighbourhood SEP for COVID-19 deaths per population, per test, or per 
positive test in the baseline analysis or in sensitivity analyses: (1) excluding all cases geocoded from the postcode 
only and (2) excluding cases with a residential address corresponding to retirement or nursing homes. (B) Adjusted 
IRRs for COVID-19 deaths per positive test by age group, sex, and epidemic wave. IRR=incidence rate ratio. 
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access and uptake of COVID-19 vaccination, and outcomes 
of COVID-19. Governments and health-care systems 
should address this pandemic of inequality by taking 
measures to reduce health inequalities in their response 
to the SARS-CoV-2 pandemic.36 
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